期刊文献+

肾脏疾病患者血清中ANCA的荧光模式及其意义 被引量:7

The significance of fluorescent patterns of antineutrophil cytoplasmic antibodies (ANCA) in renal diseases
原文传递
导出
摘要 目的 :进一步探讨肾脏疾病患者血清中抗中性粒细胞细胞质抗体 (ANCA)的荧光模式及其意义。方法 :应用间接免疫荧光(IIF)和ELISA方法检测了 2 5 1例肾脏疾病患者血清中ANCA及其靶抗原。结果 :在 2 5 1例肾脏疾病患者中 ,ANCA阳性 5 1例占 2 0 .3% ,其中 10例为cANCA阳性 (10 / 2 5 1) ;30例为pANCA阳性 (30 / 2 5 1) ;11例为aANCA阳性 (11/ 2 5 1)。结论 :同时用IIF法和ELISA法检测ANCA ,可以提高ANCA检出的阳性率 ;不同ANCA荧光模式与疾病的种类病情及预后密切相关 ;提高对不典型ANCA和 pANCA伴ANA荧光模式的鉴别 。 AIM: To further explore significance of fluorescent patterns of antineutrophil cytoplasmic antibodies in renal diseases. METHODS: ANCA fluorescent patterns and its target antigens in sera of 251 patients with renal diseases were detected by indirect immunofluorescence (IIF) and ELISA. RESULTS: The positive percentage of ANCA is 20.3% (51/251), in which 3.98%(10/251) is cANCA, 11.95% (30/251) pANCA and 4.38%(11/251) aANCA. CONCLUSION: The simultaneous screening for ANCA and its target antigens by IIF and ELISA can increase the positive percentage of ANCA in renal diseases. This novel screening strategy is able to distinguish atypical ANCA(aANCA) from pANCA with ANA and therefore useful for differential diagnosis between vasculitis and autoimmune diseases.
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2003年第2期185-186,189,共3页 Chinese Journal of Cellular and Molecular Immunology
关键词 肾脏疾病 诊断 抗中性粒细胞细胞质抗体 荧光模式 免疫荧光试验 ELISA法 antineutrophil cytoplasmic antibodies ANCA immunofluorescence ELISA renal diseases
  • 相关文献

参考文献2

共引文献8

同被引文献28

  • 1谌贻璞.系统性疾病继发肾损害狼疮性肾炎[J].医师进修杂志,1994,17(12):1-2. 被引量:2
  • 2侯巍,惠艳.65例系统性红斑狼疮患者抗中性粒细胞胞浆抗体的检测分析[J].地方病通报,2005,20(2):98-99. 被引量:2
  • 3Gross W I,Csemok E. Immunodiagnostic and pathophysiological aspects of antineutrophil cytoplasmic autoantibodies in vasculities [J ]. J Curr Opin Rheumato, 1995,7 (1): 11-19.
  • 4Franssen C F M, Stegen C A, Kallenberg M, et al. Antiproteinase 3 and antimyeloperoxidase associated vasculitis[J]. J Kid Intern,2000,57(1):2 195-2 206.
  • 5Molnar K, Kovacs L, Kiss M, et al. Antineutrophil cytoplasmic antibodies in patients with systemicclupus erythematosus [J]. Clin Exp Dermatol, 2002,27 (1):59-61.
  • 6Gross W L, Cse mok E. Immumodiagnostic and pathophysiological aspects of antineutrophil cytoplasmic autoantibodies in vasculities [J]. Curr Opin Rheumatol, 1995,7(1 ) : 11-19.
  • 7Manolov L, Dancheva M, Halacheva K. Antineutrophil cytoplasmic antibodies in patients with systemic lupus erythematosus : prevalene, antigen Specificity,and clinical associations[J]. Rheumatol Int, 2001,20 (5) : 197-204.
  • 8Chin HJ,Ahn C,Lim CS,et al. Clinical implications of antineutrophrol cytoplasmic antibody test in lupus nephritis[J]. Am J Nephrol , 2000 , 20 (1 ):57-63.
  • 9Chikazawa H, Nishiya K, Matsumori A, et al. Immunoglobulin isotypes of antimyeloperoxidase and anti-lactoferrin antibodies in patients with collagen diseases[J]. J Clin Immunol, 2000,20 (4) : 279-286.
  • 10Schnabel A,Cseronk E, Lsenberg DA,et al. Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus : prevalence ,speceficities ,and clinical significance[J]. Arthritis Rheum, 1995,38(5) :633-637.

引证文献7

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部